No. THCA is classified as a narcotic under Sweden’s Narkotikastrafflagen (1968:64), aligning with EU-wide controls on THC precursors. The Läkemedelsverket (Medical Products Agency) enforces strict prohibitions, treating THCA as equivalent to delta-9-THC due to its metabolic conversion. Recent 2026 amendments to the Narkotikaförordningen (Narcotics Ordinance) explicitly expanded the definition of “narcotic substances” to include all tetrahydrocannabinol isomers, closing prior loopholes.
Key Regulations for THCA in Sweden
- Narcotic Classification: THCA is listed under Annex I of the Narkotikastrafflagen, criminalizing possession, sale, or production without a Läkemedelsverket-issued license.
- THC Equivalence Clause: The 2026 revision of the Narkotikaförordningen (SFS 2026:12) mandates that all THCA forms—regardless of origin (hemp or cannabis)—are treated as delta-9-THC equivalents for enforcement purposes.
- Licensing Exceptions: Only pharmaceutical-grade THCA derivatives (e.g., Epidyolex) approved by the Läkemedelsverket are exempt, requiring rigorous clinical trial compliance under Läkemedelslagen (1992:859).
Swedish customs (Tullverket) and police conduct routine screenings for THCA in hemp products, with penalties ranging from fines to 3 years’ imprisonment under Brottsbalken (1962:700). Hemp cultivators must adhere to Jordbruksverket’s 2025 guidelines, which cap THC content at 0.2%—rendering THCA-rich strains non-compliant.